Ocular Therapeutix Inc (NASDAQ: OCUL) is 74.89% higher on its value in year-to-date trading and has touched a low of $2.00 and a high of $11.31 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The OCUL stock was last observed hovering at around $7.99 in the last trading session, with the day’s loss setting it -0.19%.
Currently trading at $7.80, the stock is -12.37% and -7.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.49 million and changing -2.38% at the moment leaves the stock 59.94% off its SMA200. OCUL registered 44.71% gain for a year compared to 6-month gain of 208.30%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -15.77% loss in the last 1 month and extending the period to 3 months gives it a 77.88%, and is -2.38% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.15% over the week and 5.92% over the month.
Ocular Therapeutix Inc (OCUL) has around 267 employees, a market worth around $1.16B and $58.44M in sales. Profit margin for the company is -138.14%. Distance from 52-week low is 290.98% and -31.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-46.69%).
The EPS is expected to grow by 17.45% this year.
Ocular Therapeutix Inc (OCUL) Top Institutional Holders
The shares outstanding are 148.63M, and float is at 135.05M with Short Float at 8.74%.
Ocular Therapeutix Inc (OCUL) Insider Activity
The most recent transaction is an insider purchase by SUMMER ROAD LLC,the company’s10% Owner. SEC filings show that SUMMER ROAD LLC bought 930,851 shares of the company’s common stock on Feb 26 ’24 at a price of $7.52 per share for a total of $7.0 million. Following the purchase, the insider now owns 8.59 million shares.
Ocular Therapeutix Inc disclosed in a document filed with the SEC on Jan 31 ’24 that Mattessich Antony C. (President and CEO) sold a total of 18,338 shares of the company’s common stock. The trade occurred on Jan 31 ’24 and was made at $4.95 per share for $90773.0. Following the transaction, the insider now directly holds 0.43 million shares of the OCUL stock.
Still, SEC filings show that on Jan 31 ’24, Ozden Rabia Gurses (Chief Medical Officer) disposed off 7,764 shares at an average price of $4.95 for $38432.0. The insider now directly holds 92,767 shares of Ocular Therapeutix Inc (OCUL).
